BLOG

Part 4: Macro-Insights for Industry

Part 4: Macro-Insights for Industry

Part 4: Macro-Insights for Industry  5 Macro-Insights for Industry  The FDA Proposed Rules are poised to have sweeping and substantial impact across the life sciences supply chain. Here are 5 key considerations for industry: 1. Timeline  With the comment period...

read more
NABP
Optum Rx & NABP DDA Lawsuit Update

Optum Rx & NABP DDA Lawsuit Update

Optum Rx’s requirement for their network pharmacies to only purchase prescription drug and diabetic testing supplies from Accredited wholesalers has caused significant disruption and controversy since its implementation in August 2016. The requirement spurred two separate lawsuits. The second, which continues in full force, has a recent amended complaint – and Pharma Solutions has unique insight into the lawsuit’s developments.

read more

Email Newsletter